Report Detail
Global Monoclonal Mouse Antibody Market Growth (Status and Outlook) 2019-2024
- RnM2988737 |
- 20 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Other
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
For antibody discovery, mice are one of the most important sources. They produce similar antibody isotypes with human, including IgA, IgD, IgE, IgG and IgM. Compared with the subclasses of human antibody isotypes, mice contain only one IgA class and the IgG subclasses are known as IgG1, IgG2a, IgG2b and IgG3. In addition, laboratory mice can induce a good immune response to a great range of antigens, even those highly homological human proteins. Moreover, some treatments that unacceptable for humans can also be aboveboard applied for mice with results which are analogous to that from humans. Therefore, the development of mouse monoclonal antibodies is a common choice for a variety of therapeutics and pathology researches. Up to now, the rapid development of therapeutic antibody in the pharmaceutical industry has enabled the mice to play an important role in both monoclonal antibodies discovery and the pre-clinical assessment.
The key players are Roche, Johnson & Johnson, Merck, Novartis, AbbVie, Amgen, Pfizer, Bayer, Lilly, Bristol-Myers Squibb, GlaxoSmithKline, Biogen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Seattle Genetics and so on.
The leading companies own the advantages on better performance, more abundant product’s types, better technical and impeccable after-sales service. Consequently, they take the majority of the market share of high-end market. Looking to the future years, the slow downward price trend in recent years will maintain. As competition intensifies, prices gap between different brands will go narrowing. Similarly, there will be fluctuation in gross margin.
According to this study, over the next five years the Monoclonal Mouse Antibody market will register a 5.3% CAGR in terms of revenue, the global market size will reach US$ 9990 million by 2024, from US$ 7330 million in 2019. In particular, this report presents the global revenue market share of key companies in Monoclonal Mouse Antibody business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Monoclonal Mouse Antibody market by product type, application, key companies and key regions.
This study considers the Monoclonal Mouse Antibody value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
IgM
IgG
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Therapeutic
Research
Diagnostic
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Roche
Johnson & Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Monoclonal Mouse Antibody market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Monoclonal Mouse Antibody market by identifying its various subsegments.
Focuses on the key global Monoclonal Mouse Antibody players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Monoclonal Mouse Antibody with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Monoclonal Mouse Antibody submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Monoclonal Mouse Antibody Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Monoclonal Mouse Antibody Market Size 2014-2024
- 2.1.2 Monoclonal Mouse Antibody Market Size CAGR by Region
- 2.2 Monoclonal Mouse Antibody Segment by Type
- 2.2.1 IgM
- 2.2.2 IgG
- 2.2.3 IgA
- 2.2.4 Other
- 2.3 Monoclonal Mouse Antibody Market Size by Type
- 2.3.1 Global Monoclonal Mouse Antibody Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Monoclonal Mouse Antibody Market Size Growth Rate by Type (2014-2019)
- 2.4 Monoclonal Mouse Antibody Segment by Application
- 2.4.1 Therapeutic
- 2.4.2 Research
- 2.4.3 Diagnostic
- 2.5 Monoclonal Mouse Antibody Market Size by Application
- 2.5.1 Global Monoclonal Mouse Antibody Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Monoclonal Mouse Antibody Market Size Growth Rate by Application (2014-2019)
3 Global Monoclonal Mouse Antibody by Players
- 3.1 Global Monoclonal Mouse Antibody Market Size Market Share by Players
- 3.1.1 Global Monoclonal Mouse Antibody Market Size by Players (2017-2019)
- 3.1.2 Global Monoclonal Mouse Antibody Market Size Market Share by Players (2017-2019)
- 3.2 Global Monoclonal Mouse Antibody Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Monoclonal Mouse Antibody by Regions
- 4.1 Monoclonal Mouse Antibody Market Size by Regions
- 4.2 Americas Monoclonal Mouse Antibody Market Size Growth
- 4.3 APAC Monoclonal Mouse Antibody Market Size Growth
- 4.4 Europe Monoclonal Mouse Antibody Market Size Growth
- 4.5 Middle East & Africa Monoclonal Mouse Antibody Market Size Growth
5 Americas
- 5.1 Americas Monoclonal Mouse Antibody Market Size by Countries
- 5.2 Americas Monoclonal Mouse Antibody Market Size by Type
- 5.3 Americas Monoclonal Mouse Antibody Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Monoclonal Mouse Antibody Market Size by Countries
- 6.2 APAC Monoclonal Mouse Antibody Market Size by Type
- 6.3 APAC Monoclonal Mouse Antibody Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Monoclonal Mouse Antibody by Countries
- 7.2 Europe Monoclonal Mouse Antibody Market Size by Type
- 7.3 Europe Monoclonal Mouse Antibody Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Monoclonal Mouse Antibody by Countries
- 8.2 Middle East & Africa Monoclonal Mouse Antibody Market Size by Type
- 8.3 Middle East & Africa Monoclonal Mouse Antibody Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Monoclonal Mouse Antibody Market Forecast
- 10.1 Global Monoclonal Mouse Antibody Market Size Forecast (2019-2024)
- 10.2 Global Monoclonal Mouse Antibody Forecast by Regions
- 10.2.1 Global Monoclonal Mouse Antibody Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Monoclonal Mouse Antibody Forecast by Type
- 10.8 Global Monoclonal Mouse Antibody Forecast by Application
11 Key Players Analysis
- 11.1 Roche
- 11.1.1 Company Details
- 11.1.2 Monoclonal Mouse Antibody Product Offered
- 11.1.3 Roche Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Roche News
- 11.2 Johnson & Johnson
- 11.2.1 Company Details
- 11.2.2 Monoclonal Mouse Antibody Product Offered
- 11.2.3 Johnson & Johnson Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Johnson & Johnson News
- 11.3 Merck
- 11.3.1 Company Details
- 11.3.2 Monoclonal Mouse Antibody Product Offered
- 11.3.3 Merck Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Merck News
- 11.4 Novartis
- 11.4.1 Company Details
- 11.4.2 Monoclonal Mouse Antibody Product Offered
- 11.4.3 Novartis Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Novartis News
- 11.5 AbbVie
- 11.5.1 Company Details
- 11.5.2 Monoclonal Mouse Antibody Product Offered
- 11.5.3 AbbVie Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 AbbVie News
- 11.6 Amgen
- 11.6.1 Company Details
- 11.6.2 Monoclonal Mouse Antibody Product Offered
- 11.6.3 Amgen Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Amgen News
- 11.7 Pfizer
- 11.7.1 Company Details
- 11.7.2 Monoclonal Mouse Antibody Product Offered
- 11.7.3 Pfizer Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Pfizer News
- 11.8 Bayer
- 11.8.1 Company Details
- 11.8.2 Monoclonal Mouse Antibody Product Offered
- 11.8.3 Bayer Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Bayer News
- 11.9 Lilly
- 11.9.1 Company Details
- 11.9.2 Monoclonal Mouse Antibody Product Offered
- 11.9.3 Lilly Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Lilly News
- 11.10 Bristol-Myers Squibb
- 11.10.1 Company Details
- 11.10.2 Monoclonal Mouse Antibody Product Offered
- 11.10.3 Bristol-Myers Squibb Monoclonal Mouse Antibody Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Bristol-Myers Squibb News
- 11.11 GlaxoSmithKline
- 11.12 Biogen
- 11.13 AstraZeneca
- 11.14 Sanofi
- 11.15 Alexion Pharmaceuticals
- 11.16 Seattle Genetics
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Monoclonal Mouse Antibody . Industry analysis & Market Report on Monoclonal Mouse Antibody is a syndicated market report, published as Global Monoclonal Mouse Antibody Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Monoclonal Mouse Antibody market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
